Targeting the transcription factor SPI1 attenuates neuroinflammation and dopaminergic degeneration in Parkinson’s disease via the tim-3/NF-κb axis

Neurotherapeutics · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles